Αρχική World News New 5-Minute Injection Reduces Time Breast Cancer Patients Spend in Treatment

New 5-Minute Injection Reduces Time Breast Cancer Patients Spend in Treatment

There’s a lot that’s unpleasant about having breast cancer, but one of the hardest things for many patients is how much time they have to spend at the hospital undergoing treatment. But hopefully, that’s all about to change for many patients.

Typically, when a breast cancer patient undergoes chemotherapy infusions, it can take up to two and a half hours per session to have the treatment done. For patients in the UK, however, a new treatment is being rolled out that takes just five minutes to prepare and administer.

Photo: Adobe Stock/Louise

The new treatment, called PHESGO, is a combined injection of pertuzumab with trastuzumab, which would usually have to be given as two separate infusions. Because it only takes five minutes to prepare the mixture and inject it into the patient, it’s cutting out hours of chemotherapy time for about 3,600 HER2-positive breast cancer patients each year across the country, on top of those patients currently on chemo infusions who will be switching to the new treatment. HER2-positive cancer accounts for about 15 percent of all breast cancers, meaning a large percentage of patients will be positively affected by this change.

“Approval of Phesgo being used on the NHS in England is fantastic news, as thousands of women with HER2-positive breast cancer will now benefit from a quicker and kinder treatment method,” says Baroness Delyth Morgan, Chief Executive at Breast Cancer Now. “Reducing the time patients need to spend in hospital, this more efficient treatment method also promises to free up precious time for healthcare professionals when the NHS is already under unprecedented strain due to COVID-19.”

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

Photo: YouTube/Clatterbridge NHS

This means nurses and doctors may be able to free up more time to see more patients or spend more time with other patients who need them. It also means patients get to spend more time at home recovering, or, if they’re working, they’ll be able to take less time off work for treatment.

“I’m currently on a combination of medications which take about an hour and a half to two hours to administer all together, and I have to go into hospital to have them every three weeks,” says 51-year-old Paula Lamb, who is receiving treatment at The Clatterbridge Cancer Centre for breast cancer and secondary lung and liver cancers.

She continues, “It feels absolutely amazing to be one of the first people to receive this treatment through the NHS, and it really could not have come at a better time as lockdown lifts and I can stop shielding. Having a five-minute treatment means I’ll have more time to get out on walks, for my gardening, knitting, and to help my daughter practise her cricket skills. It’s a real life-changer.”

Photo: YouTube/Clatterbridge NHS

The new treatment also significantly reduces cancer patients’ risk of contracting the COVID-19 virus, because it cuts down on the amount of time they’ll spend around other people in the hospital. Since the start of the pandemic, 228,000 people have begun NHS treatment for cancer in the UK, and there have been double the number of cancer procedures during that time as there were COVID-19 patients. This is proof that cancer should be a top priority and deserves treatment breakthroughs like this one.

“The NHS has continued to adopt new treatments rapidly throughout the pandemic, to improve cancer care for patients,” says Peter Johnson, NHS national clinical director for cancer. “This new injection, which can substantially cut treatment time for people with breast cancer, is the latest in a series of changes which have meant the NHS has been able to deliver vital cancer treatment while keeping patients safe from COVID.”

Photo: Adobe Stock/Nomad_Soul

He continues, “I am delighted that this is now available to people having breast cancer treatment, limiting the time they need to spend in hospital and giving the NHS another way to continue treating as many cancer patients as possible, as we have done throughout the pandemic.”

PHESGO may also be taken on its own or alongside traditional chemotherapy, which may make treatment more effective for difficult cases.

We hope that the PHESGO rollout will continue to go well in the UK and that it will be able to spread to other countries soon. The massive reduction in strain it could have on patients and on the healthcare system is something to look forward to for sure!

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Foodie Friday: It’s Berry Season!

July is National Berry Month! If berries aren’t part of your daily diet, now is the perfect time to start eating more of these...

No Link Between Viral Vector in Zynteglo and Acute Myeloid Leukaemia

On 23 July 2021, the European Medicines Agency (EMA) announced that its Committee for Medicinal Products for Human Use (CHMP) has endorsed findings of...

Expecting Mom Finds Pregnant Stray Cat And Gives Her A Home

A woman was 9 months pregnant when she found a pregnant stray cat. Unable to bear the thought of the fellow mom giving birth...

3 Questions Cancer Caregivers Can Ask Themselves to Help Prevent Burnout

Karen Warner Schueler is the president of her own executive coaching firm and author of The Sudden Caregiver: A Roadmap for Resilient Caregiving. For...

FDA Approval of Rylaze Will Address Drug Shortage for Childhood ALL

July 29, 2021, by NCI Staff FDA's approval of Rylaze is expected to help address a long-running shortage of the drug Erwinia asparaginase for kids...

EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib

On 22 July 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...